The authors considered this mutation pathogenic since it was compatible with the clinical presentation of both PEO and peripheral neuropathy, and the mutated amino acid was very close to motif A in the polymerase region of POLG; additionally, this mutation was not found in 130 healthy controls. This evidence concerns the gene POLG and peripheral neuropathy.